Ortec Announces Claims Approval
September 22, 2006 | By: Katie Schaefer
Ortec International Inc. has announced that the US Patent and Trademark Office (USPTO) has approved claims for the second patent application of its Haptides technology platform. "This represents the second patent to be granted in the US covering the Haptides technology, a versatile technology which we believe can improve the efficacy of an array of current biomaterials in the market place today. We are actively pursuing licensing opportunities with this proprietary peptide with companies focused on the orthopedic, dental, and cosmetic markets, and we believe the newly granted claims further enhance Haptides’ potential value,” commented Ortec's Vice Chairman and CEO Ron Lipstein.
Z-COTE LSA provides broad-spectrum protection from long wave UVA rays and medium wave UVB rays by physically scattering, reflecting and absorbing solar radiation.
- Zinc Oxide
- UVA, UVB Sunscreen
- UVA Protection
- UVB Protection